ReviewFrontiers in immunology2026
Is hidradenitis suppurativa more an autoinfection than pure autoinflammation?
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hidradenitis suppurativa is currently considered an autoinflammatory disease. However, the cause of this inflammation remains unknown. Over the past 18 years, we have followed a cohort of 1,700 patients with hidradenitis suppurativa and identified, both in the literature and in our daily practice, several arguments suggesting that hidradenitis suppurativa represents a new concept of host-microbiome disease. This concept is based on an inborn error of immunity localized to a single organ-the skin-or, in special cases, to two or more organs. In this article, we detail the microbiological, immunologic, metabolomic, therapeutic, and genetic evidence supporting the view that HS should be redefined as an autoinfectious rather than a purely autoinflammatory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.